Curiously, some of them displayed significantly up-regulation upon 5AzaCdR treatment in 4C11+ melanoma cell such as Fblim1 (Table S4), a cytoskeleton regulator that can control integrin activation and cancer progression [26]. Here, FBLIM1 is linked to cancer.